Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of ACT-541468 and Ethanol Interactions in Healthy Subjects
NCT03609775Phase 1Completed
- Sponsor
- Idorsia
- Start
- Aug 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of daridorexant in Insomnia (4 arms), sponsored by Idorsia. Primary endpoint: Change from baseline for saccadic peak velocity. Started Aug 2018; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03609775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609775.